-
公开(公告)号：US20220056123A1
公开(公告)日：2022-02-24
申请号：US17415298
申请日：2019-12-18
Applicant: NOVARTIS AG
Inventor： Mark SHILKRUT , Michelle TSAI , Connie WONG
Abstract: Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of a cancer having at least a partial inflammatory basis.
Search Results
1
records
(took 0.01 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
